These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37975059)

  • 1. Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical Trial.
    Mehtani R; Premkumar M; Garg S; Kajal K; Kulkarni AV; Duseja AK; Dhiman RK; De A; Verma N; Taneja S; Rathi S; Singh V; Chakma J; Soni SL; Kakkar A; Kapila AT; Ahuja CK; Divyaveer S; Praharaj D
    J Clin Exp Hepatol; 2023; 13(6):977-988. PubMed ID: 37975059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure.
    Ahmed S; Premkumar M; Dhiman RK; Kulkarni AV; Imran R; Duseja A; Kaur P; Taneja S; Singh V; Mishra S; Roy A; Mehtani R
    J Clin Gastroenterol; 2022 Jan; 56(1):e11-e19. PubMed ID: 33060437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial.
    Rahimi RS; Singal AG; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2014 Nov; 174(11):1727-33. PubMed ID: 25243839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The
    Xia L; Qiao ZY; Zhang ZJ; Lv ZC; Tong H; Tong Y; Wu HX; Chen XS; Sun HY; Zhang JJ; Thasler WE; Feng H; Xia Q
    EClinicalMedicine; 2022 Jul; 49():101476. PubMed ID: 35747194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy.
    Sharma BC; Singh J; Srivastava S; Sangam A; Mantri AK; Trehanpati N; Sarin SK
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1234-1239. PubMed ID: 27885712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of minimal and overt hepatic encephalopathy with branched-chain amino acids: a review of the evidence.
    Swansson WD; Anderson BM; Yeoh SW; Lewis DJ
    Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):812-821. PubMed ID: 37395232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.
    Gupta T; Dhiman RK; Rathi S; Agrawal S; Duseja A; Taneja S; Chawla Y
    J Clin Exp Hepatol; 2017 Mar; 7(1):9-15. PubMed ID: 28348465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living Donor Liver Transplantation for Acute on Chronic Liver Failure Based on EASL-CLIF Diagnostic Criteria.
    Bhatti ABH; Dar FS; Butt MO; Sahaab E; Salih M; Shah NH; Khan NY; Zia HH; Khan EU; Khan NA
    J Clin Exp Hepatol; 2018 Jun; 8(2):136-143. PubMed ID: 29892176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Gluud LL; Dam G; Borre M; Les I; Cordoba J; Marchesini G; Aagaard NK; Vilstrup H
    Metab Brain Dis; 2013 Jun; 28(2):221-5. PubMed ID: 23275147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure.
    Verma N; Dhiman RK; Choudhury A; Taneja S; Duseja A; Singh V; Al Mahtab M; Devarbhavi H; Shukla A; Ning Q; Hamid SS; Butt AS; Jafri W; Tan SS; Hu J; Zhongping D; Treeprasertsuk S; Lee GH; Ghazinyan H; Lesmana LA; Sood A; Midha V; Goyal O; Kim DJ; Eapen CE; Goel A; Tao H; Shaojie X; Yuemin N; Dokmeci AK; Sahu M; Singh A; Arora A; Kumar A; Kumar R; Prasad VGM; Shresta A; Sollano J; Payawal DA; Shah S; Rao PN; Kulkarni A; Lau GK; Sarin SK;
    Hepatol Int; 2021 Aug; 15(4):970-982. PubMed ID: 34275111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure.
    Chiriac S; Stanciu C; Cojocariu C; Singeap AM; Sfarti C; Cuciureanu T; Girleanu I; Igna RA; Trifan A
    World J Clin Cases; 2021 Jan; 9(3):552-564. PubMed ID: 33553393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
    Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
    Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
    Jain A; Sharma BC; Mahajan B; Srivastava S; Kumar A; Sachdeva S; Sonika U; Dalal A
    Hepatology; 2022 May; 75(5):1194-1203. PubMed ID: 34822189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.